Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
54.4M
-
Shares change
-
+749K
-
Total reported value, excl. options
-
$1.33B
-
Value change
-
+$21.9M
-
Put/Call ratio
-
0.76
-
Number of buys
-
75
-
Number of sells
-
-45
-
Price
-
$24.42
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q2 2015
141 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q2 2015.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.4M shares
of 211M outstanding shares and own 25.8% of the company stock.
Largest 10 shareholders include FMR LLC (9.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.65M shares), Palo Alto Investors, LLC (4.73M shares), BlackRock Fund Advisors (2.27M shares), JANUS CAPITAL MANAGEMENT LLC (2.24M shares), JPMORGAN CHASE & CO (2.12M shares), STATE STREET CORP (2.08M shares), VANGUARD GROUP INC (1.94M shares), ORBIMED ADVISORS LLC (1.71M shares), and BAKER BROS. ADVISORS LP (1.58M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.